🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study, the efficacy and safety of two nilotinib doses, 300 mg twice...
Status
Completed
Location
University of California at Los Angeles Dept. of Hematology Clinic
Start Date
2007-07-31
Trial ID
NCT00471497
Maintain and monitor long-term hematological and cytogenetic responses prev...
Status
Completed
Location
Novartis Investigative Site
Start Date
2008-08
Trial ID
NCT00786812
Treatments Being Tested
The purpose of this study is to determine whether nilotinib is efficacious ...
Status
Completed
Location
City of Hope National Medical Center City of Hope national Med Ctr
Start Date
2010-06
Trial ID
NCT01028222
The main purpose of this study was to evaluate the rate of deep molecular r...
Status
Completed
Location
Novartis Investigative Site
Start Date
2016-02-18
Trial ID
NCT02546674
Treatments Being Tested
Patients with acute lymphoblastic leukemia and positivity for the breakpoin...
Status
Terminated
Location
Multiple Locations
Start Date
2009-05
Trial ID
NCT00905398
Treatments Being Tested
The goal of this clinical research study is to learn if Tasigna® (nilotinib...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-01
Trial ID
NCT01270893
Treatments Being Tested
This phase II ComboMATCH treatment trial evaluates nilotinib with paclitaxe...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-07-14
Trial ID
NCT05554341
In this study, the efficacy of nilotinib at 400 mg BID will be compared wit...
Status
Unknown
Location
Seoul St. Mary's Hospital
Start Date
2009-01
Trial ID
NCT01400074
Treatments Being Tested
This study will evaluate the effects of multiple doses of nilotinib on the ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-06
Trial ID
NCT01223898
Treatments Being Tested
This ComboMATCH patient screening trial is the gateway to a coordinated set...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2023-04-07
Trial ID
NCT05564377
Treatments Being Tested